PSTR yields 5.12% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 10
Combined, PSTR + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PSTR + JNJ for your $10,000?
PSTR pursues favorable returns by continuously evaluating economic, political, and market conditions to identify opportunities and mitigate potential declines. Portfolio allocation is based on forecasting methods, incorporating sector analysis and top-down macroeconomic indicators like key industry drivers, financial metrics, and return forecasts. Additionally, bottom-up fundamental analysis of individual securities is also part of the approach. While it maintains core investments in sectors represented in the S&P 500, it periodically shifts selection and weighting towards sectors across the broader domestic market. The strategy is intended to capitalize on the potential alpha arising from variations between sector allocations and the broad market. To further enhance returns and generate income, it utilizes a covered call option writing strategy. The fund may engage in active and frequent trading. Investments may include equity ETFs and derivatives.
Full PSTR Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.